These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 11399535

  • 1. Androgen responsive genes as they affect hair growth.
    Sawaya ME, Keane RW, Blume-Peytavi U, Mullins DL, Nusbaum BP, Whiting D, Nicholson DW.
    Eur J Dermatol; 2001; 11(4):304-8. PubMed ID: 11399535
    [Abstract] [Full Text] [Related]

  • 2. Caspase-1 level is higher in the scalp in androgenetic alopecia.
    de Rivero Vaccari JP, Sawaya ME, Brand F, Nusbaum BP, Bauman AJ, Bramlett HM, Dietrich WD, Keane RW.
    Dermatol Surg; 2012 Jul; 38(7 Pt 1):1033-9. PubMed ID: 22404322
    [Abstract] [Full Text] [Related]

  • 3. Effects of finasteride on apoptosis and regulation of the human hair cycle.
    Sawaya ME, Blume-Peytavi U, Mullins DL, Nusbaum BP, Whiting D, Nicholson DW, Lotocki G, Keane RW.
    J Cutan Med Surg; 2002 Jul; 6(1):1-9. PubMed ID: 11896416
    [Abstract] [Full Text] [Related]

  • 4. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia.
    Drake L, Hordinsky M, Fiedler V, Swinehart J, Unger WP, Cotterill PC, Thiboutot DM, Lowe N, Jacobson C, Whiting D, Stieglitz S, Kraus SJ, Griffin EI, Weiss D, Carrington P, Gencheff C, Cole GW, Pariser DM, Epstein ES, Tanaka W, Dallob A, Vandormael K, Geissler L, Waldstreicher J.
    J Am Acad Dermatol; 1999 Oct; 41(4):550-4. PubMed ID: 10495374
    [Abstract] [Full Text] [Related]

  • 5. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
    Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, Fiedler V, Lucky A, Whiting DA, Pappas F, Culbertson J, Kotey P, Meehan A, Waldstreicher J.
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579
    [Abstract] [Full Text] [Related]

  • 6. Advances in the treatment of male androgenetic alopecia: a brief review of finasteride studies.
    Whiting DA.
    Eur J Dermatol; 2001 Nov; 11(4):332-4. PubMed ID: 11399540
    [Abstract] [Full Text] [Related]

  • 7. Natural scalp hair regression in preclinical stages of male androgenetic alopecia and its reversal by finasteride.
    Van Neste D.
    Skin Pharmacol Physiol; 2006 Nov; 19(3):168-76. PubMed ID: 16679818
    [Abstract] [Full Text] [Related]

  • 8. Enzymology of the hair follicle.
    Hoffmann R.
    Eur J Dermatol; 2001 Nov; 11(4):296-300. PubMed ID: 11399533
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of androgens in the scalp hair and plasma of patients with male-pattern baldness before and after finasteride administration.
    Ryu HK, Kim KM, Yoo EA, Sim WY, Chung BC.
    Br J Dermatol; 2006 Apr; 154(4):730-4. PubMed ID: 16536818
    [Abstract] [Full Text] [Related]

  • 10. Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year results.
    Price VH, Menefee E, Sanchez M, Kaufman KD.
    J Am Acad Dermatol; 2006 Jul; 55(1):71-4. PubMed ID: 16781295
    [Abstract] [Full Text] [Related]

  • 11. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA, Hordinsky M, Whiting D, Stough D, Hobbs S, Ellis ML, Wilson T, Rittmaster RS, Dutasteride Alopecia Research Team.
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [Abstract] [Full Text] [Related]

  • 12. Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss.
    Roberts JL, Fiedler V, Imperato-McGinley J, Whiting D, Olsen E, Shupack J, Stough D, DeVillez R, Rietschel R, Savin R, Bergfeld W, Swinehart J, Funicella T, Hordinsky M, Lowe N, Katz I, Lucky A, Drake L, Price VH, Weiss D, Whitmore E, Millikan L, Muller S, Gencheff C.
    J Am Acad Dermatol; 1999 Oct; 41(4):555-63. PubMed ID: 10495375
    [Abstract] [Full Text] [Related]

  • 13. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old.
    Camacho FM, García-Hernández MJ, Fernández-Crehuet JL.
    Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752
    [Abstract] [Full Text] [Related]

  • 14. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled observational data in placebo-treated patients.
    Kaufman KD, Girman CJ, Round EM, Johnson-Levonas AO, Shah AK, Rotonda J.
    Eur J Dermatol; 2008 May; 18(4):407-11. PubMed ID: 18573713
    [Abstract] [Full Text] [Related]

  • 15. Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro.
    Fischer TW, Hipler UC, Elsner P.
    Int J Dermatol; 2007 Jan; 46(1):27-35. PubMed ID: 17214716
    [Abstract] [Full Text] [Related]

  • 16. [Hormonal interaction and hair growth].
    Hoffmann R.
    Ann Dermatol Venereol; 2002 May; 129(5 Pt 2):787-92. PubMed ID: 12223960
    [Abstract] [Full Text] [Related]

  • 17. Influence of estrogens on the androgen metabolism in different subunits of human hair follicles.
    Niiyama S, Happle R, Hoffmann R.
    Eur J Dermatol; 2001 May; 11(3):195-8. PubMed ID: 11358723
    [Abstract] [Full Text] [Related]

  • 18. [Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
    Wolff H, Kunte C.
    MMW Fortschr Med; 1999 Sep 16; 141(37):38-40. PubMed ID: 10897972
    [Abstract] [Full Text] [Related]

  • 19. An investigation of apoptosis in androgenetic alopecia.
    Morgan MB, Rose P.
    Ann Clin Lab Sci; 2003 Sep 16; 33(1):107-12. PubMed ID: 12661906
    [Abstract] [Full Text] [Related]

  • 20. [Hair follicle regeneration].
    Itami S.
    Nihon Rinsho; 2008 May 16; 66(5):892-6. PubMed ID: 18464507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.